Products

Eurolide 4ML (Leuprolide) Injection—Global Supplier & Exporter | Ernest Oncology Eurolide 4ML Leuprolide Injection—Hormone Therapy for Prostate Cancer & Endometriosis Eurolide 4ML Injection (Leuprolide Acetate) is a widely used hormonal therapy medicine prescribed for the treatment of prostate cancer, endometriosis, uterine fibroids, and hormone-dependent conditions. It belongs to a class of medicines called GnRH agonists (Gonadotropin-Releasing Hormone agonists) that help regulate hormone production in the body. Ernest Oncology , a trusted pharmaceutical exporter from India, supplies Eurolide 4ML (Leuprolide) Injection to international healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. Hospitals, oncology centers, gynecology clinics, pharmaceutical distributors, and healthcare procurement companies import this medicine from Ernest Oncology for reliable global supply. What is Eurolide 4ML (Leuprolide) Injection? Eurolide 4ML contains Leuprolide Acetate, a synthetic hormone that works by reducing the production of certain hormones in the body such as testosterone and estrogen. This medicine is widely used in oncology and gynecology treatments to manage hormone-dependent diseases. Leuprolide therapy helps slow disease progression and manage symptoms related to hormone imbalance. Mechanism of Action Leuprolide works by acting on the pituitary gland and suppressing the release of gonadotropins, which reduces hormone levels in the body. Key pharmacological actions include: • Reduces testosterone production in men • Reduces estrogen production in women • Slows growth of hormone-dependent tumors • Helps control symptoms of hormonal disorders Because of this targeted hormonal action, Leuprolide injections are widely used in oncology and reproductive medicine worldwide. Medical Uses of Eurolide 4ML Injection Doctors prescribe Eurolide injection for several medical conditions including: Prostate Cancer Leuprolide is widely used in the treatment of advanced prostate cancer by reducing testosterone levels that promote tumor growth. Endometriosis Helps reduce pelvic pain and abnormal tissue growth associated with endometriosis. Uterine Fibroids Used to shrink fibroids before surgery and manage symptoms. Precocious Puberty Sometimes used to treat early puberty in children. Benefits of Eurolide 4ML (Leuprolide) Injection • Effective hormone therapy for prostate cancer • Helps control hormone-dependent diseases • Reduces tumor growth signals • Improves treatment outcomes in oncology patients • Widely used in gynecology and reproductive medicine • Trusted therapy in modern medical treatment protocols Product Information Product Name: Eurolide Injection Generic Name: Leuprolide Acetate Strength: 4 ML Dosage Form: Injection Therapeutic Class: Hormonal Therapy / GnRH Agonist Indications: Prostate cancer, endometriosis, uterine fibroids Prescription: Required Global Demand for Leuprolide Injection With increasing cases of prostate cancer and hormonal disorders, medicines like Leuprolide injection are in high demand globally. Healthcare providers in USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica import these medicines from reliable pharmaceutical exporters in India such as Ernest Oncology Eurolide Injection Exporter & Supplier Ernest Oncology is a leading pharmaceutical exporter and distributor of oncology and specialty medicines from India. The company supplies medicines to: • Oncology hospitals • Gynecology clinics • Pharmaceutical wholesalers • Medical procurement companies • Government healthcare tenders • International NGOsWhy Choose Ernest Impex? • Trusted Pharmaceutical Exporter from India • Global supply network covering 100+ countries • GMP compliant medicines • Competitive wholesale pricing • Secure international packaging • Fast global delivery • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth customs clearance for international pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

VENCLEXTA 100MG Tablet (Venetoclax) Exporter & Global Oncology Supplier –Ernest Oncology VENCLEXTA 100MG Tablet contains Venetoclax, an advanced targeted anti-cancer medicine used primarily for the treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). Ernest Impex is a trusted pharmaceutical exporter from India, supplying VENCLEXTA 100MG tablets globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and healthcare procurement agencies. Pharmaceutical importers and healthcare providers across Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely on Ernest Impex for bulk supply of Venetoclax tablets with reliable global logistics and competitive export pricing. What is VENCLEXTA 100MG Tablet? VENCLEXTA 100MG Tablet contains Venetoclax, a BCL-2 inhibitor used as targeted therapy for certain blood cancers. The drug works by blocking the BCL-2 protein, which helps cancer cells survive. Cancer cells in diseases such as CLL and AML rely heavily on the BCL-2 protein to avoid programmed cell death. By inhibiting this protein, Venetoclax allows cancer cells to undergo apoptosis (natural cell death). Because of its targeted mechanism, Venetoclax has become an important breakthrough therapy in hematology and oncology treatments worldwide. Mechanism of Action The active ingredient Venetoclax selectively inhibits the B-cell lymphoma-2 (BCL-2) protein, which regulates cell survival. By blocking BCL-2, Venetoclax: • Restores the natural process of cancer cell death • Prevents survival of abnormal leukemia cells • Reduces tumor burden • Improves treatment outcomes in leukemia patients This targeted mechanism makes VENCLEXTA tablets highly effective for certain blood cancers. Medical Uses of VENCLEXTA 100MG Tablet VENCLEXTA tablets are commonly prescribed for: • Chronic Lymphocytic Leukemia (CLL) • Small Lymphocytic Lymphoma (SLL) • Acute Myeloid Leukemia (AML) in combination therapy • Targeted treatment for hematologic malignancies • Patients with relapsed or refractory leukemia Venetoclax is widely used in advanced hematology and oncology treatment programs worldwide. Product Information Product Name: VENCLEXTA 100MG Tablet Generic Name: Venetoclax Strength: 100 mg Dosage Form: Oral Tablet Therapeutic Category: Anti-Cancer / BCL-2 Inhibitor Packaging: Blister pack / Export carton packaging Shelf Life: 24–36 months Storage: Store below 25°C in a cool and dry place Benefits of VENCLEXTA Tablets • Advanced targeted therapy for leukemia treatment • Helps eliminate abnormal cancer cells • Effective treatment for CLL, SLL, and AML • Oral tablet for convenient long-term therapy • Widely used in modern hematology treatment protocols • Proven targeted therapy for blood cancers Why Choose Ernest Oncology? Ernest Oncology is a leading pharmaceutical exporter from India, supplying high-quality medicines to pharmaceutical distributors, hospitals, and healthcare institutions worldwide. Key advantages include • GMP-certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable international pharmaceutical distribution network • OEM and private labeling options available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted supplier of oncology medicines and specialty drugs Export Documentation Provided Ernest Oncology provides complete export documentation for international pharmaceutical shipments, including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

Etibo 250mg (Lapatinib) Tablets – Global Supplier & Exporter | Ernest Oncology Etibo 250mg Lapatinib Tablets – Targeted Therapy for HER2-Positive Breast Cancer Etibo 250mg Tablets (Lapatinib) are advanced targeted anti-cancer medicines used in the treatment of HER2-positive breast cancer. Lapatinib belongs to a class of drugs known as tyrosine kinase inhibitors (TKIs) that block cancer cell growth by targeting HER2 and EGFR receptors. Ernest Oncology, a trusted pharmaceutical exporter from India, supplies Etibo 250mg (Lapatinib) Tablets to international healthcare markets including Washington DC, London UK, Riyadh Saudi Arabia, Bangkok Thailand, Canberra Australia, Singapore, and Kingston Jamaica. These medicines are widely imported by oncology hospitals, cancer treatment centers, medical distributors, and pharmaceutical wholesalers worldwide. What is Etibo 250mg (Lapatinib) Tablet? Etibo 250mg contains Lapatinib, a targeted anti-cancer medication designed to treat HER2-positive metastatic breast cancer. It works by blocking specific proteins responsible for tumor growth and cancer cell proliferation. Lapatinib is often prescribed in combination with other cancer medicines such as: • Capecitabine • Letrozole • Hormonal therapies This therapy helps slow tumor growth and improve survival outcomes in breast cancer patients. Mechanism of Action of Lapatinib Lapatinib is a dual tyrosine kinase inhibitor that blocks two important cancer growth receptors: • HER2 (Human Epidermal Growth Factor Receptor 2) • EGFR (Epidermal Growth Factor Receptor) By inhibiting these receptors, Lapatinib: • Prevents cancer cell multiplication • Blocks tumor growth signals • Reduces cancer progression • Improves treatment response in HER2-positive tumors Because of this targeted mechanism, Lapatinib is widely used in modern oncology treatment protocols. Medical Uses of Etibo 250mg Tablets Etibo 250mg is commonly prescribed for: HER2-Positive Metastatic Breast Cancer Used in patients whose cancer has spread and requires targeted therapy. Advanced Breast Cancer Used when other treatments such as trastuzumab therapy are no longer effective. Combination Cancer Therapy Often combined with chemotherapy drugs to improve treatment effectiveness. Benefits of Etibo 250mg (Lapatinib) Tablets • Advanced targeted cancer therapy • Effective for HER2-positive breast cancer • Helps slow tumor growth • Used in combination with chemotherapy • Improves treatment outcomes in oncology patients • Recommended in international cancer treatment protocols Product Information Product Name: Etibo 250mg Tablet Generic Name: Lapatinib Strength: 250 mg Dosage Form: Tablet Therapeutic Class: Anti-Cancer / Tyrosine Kinase Inhibitor Indication: HER2-positive metastatic breast cancer Prescription: Required Global Demand for Lapatinib Tablets With rising cases of breast cancer worldwide, targeted therapies like Lapatinib are in high demand across global healthcare markets. Countries such as USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica regularly import oncology medicines from reliable pharmaceutical exporters in India. Etibo 250mg Tablet Exporter & Supplier Ernest Oncology is a globally recognized pharmaceutical exporter and distributor of oncology medicines from India. The company supplies anti-cancer medicines to: • Hospitals • Oncology clinics • Pharmaceutical wholesalers • Government healthcare tenders • NGOs and international procurement agencies Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global supply network covering 100+ countries • GMP compliant medicines • Competitive bulk pricing • Reliable export packaging • Fast international shipping • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides full export documentation including: • Certificate of Analysis (COA) • Manufacturing License • Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance. 📞 Contact EErnest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

TALAPARIB 1MG Capsules (Talazoparib) Exporter & Global Oncology Supplier – Ernest Oncology TALAPARIB 1MG Capsules contain Talazoparib, a targeted anti-cancer medication used primarily in the treatment of BRCA-mutated breast cancer and certain advanced cancers. Ernest Oncology is a trusted pharmaceutical exporter from India, supplying TALAPARIB 1MG Capsules globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and healthcare procurement agencies. Pharmaceutical importers and healthcare providers across Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely onErnest Oncology for bulk supply of Talazoparib capsules with reliable global logistics and competitive export pricing. What is TALAPARIB 1MG Capsule? TALAPARIB 1MG Capsule contains Talazoparib, a PARP (Poly ADP-Ribose Polymerase) inhibitor used in the treatment of HER2-negative, BRCA-mutated breast cancer and other cancers that involve DNA repair pathway mutations. Talazoparib works by blocking PARP enzymes that cancer cells rely on to repair damaged DNA. When these repair pathways are blocked, cancer cells accumulate damage and eventually die. Because of this targeted approach, Talazoparib is considered an important therapy in modern precision oncology treatments worldwide. Mechanism of Action The active ingredient Talazoparib inhibits PARP enzymes, which are essential for repairing damaged DNA in cells. By blocking PARP activity, Talazoparib: • Prevents repair of damaged DNA in cancer cells • Causes accumulation of DNA damage • Triggers cancer cell death • Slows tumor growth and progression This targeted mechanism makes TALAPARIB Capsules an effective therapy for BRCA-mutated cancers. Medical Uses of TALAPARIB 1MG Capsules TALAPARIB capsules are commonly prescribed for: • HER2-negative BRCA-mutated breast cancer • Advanced or metastatic breast cancer • Targeted therapy in oncology treatment protocols • Patients with genetic DNA repair mutations Talazoparib is widely used in specialized oncology hospitals and cancer treatment centers worldwide. Product Information Product Name: TALAPARIB 1MG Capsules Generic Name: Talazoparib Strength: 1 mg Dosage Form: Oral Capsules Therapeutic Category: Anti-Cancer / PARP Inhibitor Packaging: Blister pack / Export carton packaging Shelf Life: 24–36 months Storage: Store below 25°C in a dry place Benefits of TALAPARIB Capsules • Advanced targeted therapy for BRCA-mutated cancers • Precision medicine for breast cancer treatment • Helps slow tumor growth and progression • Oral capsule for convenient long-term therapy • Widely used in modern oncology treatment programs • Trusted targeted cancer therapy worldwide Why Choose Ernest Oncology? Ernest Oncology is a leading pharmaceutical exporter from India, supplying high-quality medicines to pharmaceutical distributors, hospitals, and healthcare institutions worldwide. Key advantages include • GMP-certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable international pharmaceutical distribution network • OEM and private labeling options available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted supplier of oncology medicines and specialty drugs Export Documentation Provided Ernest Impex provides complete export documentation for international pharmaceutical shipments including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

IVOSENIB 250MG Tablet (Ivosidenib) Exporter & Global Oncology Supplier –Ernest Oncology IVOSENIB 250MG Tablet contains Ivosidenib, a targeted anti-cancer medication used primarily for the treatment of acute myeloid leukemia (AML) and certain types of bile duct cancer (cholangiocarcinoma) associated with IDH1 gene mutations. Ernest Impex is a trusted pharmaceutical exporter from India, supplying IVOSENIB 250MG Tablets globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and healthcare procurement agencies. Pharmaceutical importers and healthcare providers across Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) depend on Ernest Impex for bulk supply of Ivosidenib tablets with reliable international delivery and competitive export pricing. What is IVOSENIB 250MG Tablet? IVOSENIB 250MG Tablet contains Ivosidenib, an oral IDH1 inhibitor used as a targeted therapy for cancers that carry mutations in the isocitrate dehydrogenase-1 (IDH1) gene. Mutations in the IDH1 gene lead to abnormal cell metabolism and cancer cell growth. Ivosidenib works by blocking the mutated enzyme and restoring normal cell differentiation. This helps reduce cancer cell growth and supports the body’s natural ability to control abnormal cells. Because of its targeted approach, Ivosidenib has become an important therapy in modern oncology treatments worldwide. Mechanism of Action The active ingredient Ivosidenib selectively inhibits the mutated IDH1 enzyme, which is responsible for producing an abnormal metabolite known as 2-hydroxyglutarate (2-HG). By blocking this abnormal metabolic pathway, Ivosidenib: • Reduces levels of the cancer-promoting metabolite 2-HG • Restores normal cell differentiation • Prevents uncontrolled cancer cell proliferation • Slows progression of leukemia and other IDH1-mutated cancers This targeted mechanism makes IVOSENIB Tablets an effective precision oncology therapy. Medical Uses of IVOSENIB 250MG Tablet IVOSENIB tablets are commonly prescribed for: • Acute Myeloid Leukemia (AML) with IDH1 mutation • Relapsed or refractory AML • Cholangiocarcinoma (bile duct cancer) with IDH1 mutation • Targeted therapy in precision oncology treatment programs Ivosidenib is widely used in specialized oncology hospitals and cancer treatment centers worldwide. Product Information Product Name: IVOSENIB 250MG Tablet Generic Name: Ivosidenib Strength: 250 mg Dosage Form: Oral Tablet Therapeutic Category: Anti-Cancer / IDH1 Inhibitor Packaging: Blister Pack / Export Carton Packaging Shelf Life: 24–36 months Storage: Store below 25°C in a cool and dry place Benefits of IVOSENIB Tablets • Advanced targeted therapy for leukemia and bile duct cancer • Precision medicine designed for IDH1 mutation cancers • Helps slow cancer progression • Oral tablet for convenient treatment • Used in modern oncology treatment programs • Trusted targeted cancer therapy worldwide Why Choose Ernest Oncology? Ernest Oncology is a leading pharmaceutical exporter from India, supplying high-quality medicines to pharmaceutical distributors, hospitals, and healthcare institutions worldwide. Key advantages include: • GMP certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable international pharmaceutical distribution network • OEM and private labeling options available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted supplier of oncology medicines and specialty drugs Export Documentation Provided Ernest Oncology provides complete export documentation for international pharmaceutical shipments including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

Endace 40mg (Megestrol) Tablet – Global Supplier & Exporter |Ernest Oncology Endace 40mg (Megestrol Acetate) Tablet – Appetite Stimulant & Oncology Support Medicine Endace 40mg Tablet (Megestrol Acetate) is a widely prescribed hormonal medicine used in the treatment of loss of appetite, unexplained weight loss, cancer-related cachexia, and AIDS-related wasting syndrome. This medication helps improve appetite and increase body weight in patients suffering from chronic illnesses or undergoing long-term medical treatments. Ernest Oncology, a leading pharmaceutical exporter from India, supplies Endace 40mg (Megestrol) Tablets to hospitals, pharmacies, oncology centers, medical distributors, and healthcare procurement companies worldwide including Washington DC, London, Riyadh, Bangkok, Canberra, Singapore, and Kingston Jamaica. What is Endace 40mg (Megestrol) Tablet? Endace 40mg contains Megestrol Acetate, a synthetic derivative of the hormone progesterone. It is commonly used in oncology supportive care to manage appetite loss and severe weight reduction associated with cancer and chronic diseases. Megestrol helps stimulate appetite and improve caloric intake, enabling patients to regain body weight and nutritional balance. Mechanism of Action Megestrol acetate works by acting on the hypothalamus, the part of the brain responsible for appetite control. Its pharmacological effects include: • Increasing appetite and food intake • Promoting weight gain and fat deposition • Reducing inflammatory cytokines responsible for cachexia • Supporting recovery in patients with chronic illness Because of these effects, Megestrol tablets are widely used in oncology and palliative care treatments worldwide. Medical Uses of Endace 40mg Tablet Doctors prescribe Endace 40mg tablets in several medical conditions, including: Cancer-Related Cachexia Cancer patients frequently experience severe weight loss and appetite reduction. Megestrol helps restore appetite and body weight. HIV/AIDS-Related Wasting Syndrome Used to treat loss of appetite and severe weight loss associated with HIV/AIDS. Hormone-Sensitive Cancers Sometimes used in the treatment of breast cancer and endometrial cancer. Chronic Illness Malnutrition Improves nutritional intake in patients suffering from long-term diseases. Benefits of Endace 40mg (Megestrol) Tablet • Powerful appetite stimulant • Helps increase body weight • Improves nutritional status in chronic illness • Supports recovery in oncology patients • Widely used in cancer supportive therapy • Clinically proven hormone therapy medicine Product Information Product Name: Endace 40mg Tablet Generic Name: Megestrol Acetate Strength: 40 mg Dosage Form: Tablet Therapeutic Class: Hormonal / Appetite Stimulant Indication: Cachexia, anorexia, cancer-related weight loss Prescription: Required Global Demand for Megestrol Tablets With increasing cases of cancer, HIV/AIDS, and chronic disease-related weight loss, Megestrol medicines such as Endace 40mg Tablet are in high demand worldwide. Healthcare providers in countries such as USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica import Megestrol tablets from reliable pharmaceutical exporters in India. Endace 40mg Tablet Exporter & Supplier Ernest Oncology is a trusted international exporter of oncology medicines and specialty pharmaceuticals from India. The company supplies medicines to global wholesalers, hospitals, government tenders, NGOs, and healthcare distributors. Our pharmaceutical export services cover major global healthcare markets. Why Choose Ernest Oncology? • Trusted Pharmaceutical Exporter from India • Global supply network covering 100+ countries • GMP compliant medicines • Competitive wholesale pricing • Reliable export packaging • Fast international shipping • Complete pharmaceutical export documentation Export Documentation Provided Ernest Oncology provides all required export documents including: • Certificate of Analysis (COA) • Manufacturing License • Product Batch Release Certificate • MSDS (Material Safety Data Sheet) • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth customs clearance for international pharmaceutical shipments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 WhatsApp Direct Link

TIVOXEN 1.34MG Capsules (Tivozanib) Exporter & Global Oncology Supplier – Ernest Oncology TIVOXEN 1.34MG Capsules contain Tivozanib, a targeted anti-cancer medication used in the treatment of advanced renal cell carcinoma (RCC), a type of kidney cancer. Ernest Oncology is a trusted pharmaceutical exporter from India, supplying TIVOXEN 1.34MG Capsules globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and medical procurement agencies. Healthcare providers and pharmaceutical importers across Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely onErnest Oncology for bulk supply of Tivozanib capsules with reliable global logistics and competitive export pricing. What is TIVOXEN 1.34MG Capsule? TIVOXEN 1.34MG Capsule contains Tivozanib, an oral vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor used for the treatment of advanced kidney cancer. Tivozanib works by blocking signals that promote the formation of new blood vessels (angiogenesis) that tumors need to grow. By preventing blood supply to cancer cells, the drug helps slow tumor growth and disease progression. Because of its targeted mechanism and effectiveness, Tivozanib has become an important therapy in modern renal cancer treatment protocols worldwide. Mechanism of Action The active ingredient Tivozanib selectively inhibits VEGF receptors (VEGFR-1, VEGFR-2, and VEGFR-3) that play a key role in tumor angiogenesis. By blocking these receptors, Tivozanib: • Prevents formation of new blood vessels feeding tumors • Reduces tumor growth and spread • Slows cancer progression • Improves treatment outcomes in renal cell carcinoma This mechanism makes TIVOXEN Capsules an effective targeted therapy for kidney cancer patients. Medical Uses of TIVOXEN 1.34MG Capsules TIVOXEN capsules are commonly prescribed for: • Advanced Renal Cell Carcinoma (Kidney Cancer) • Relapsed or refractory kidney cancer • Targeted therapy in oncology treatment protocols • Patients requiring VEGFR inhibitor therapy Tivozanib is widely used in oncology hospitals and cancer treatment centers worldwide. Product Information Product Name: TIVOXEN 1.34MG Capsules Generic Name: Tivozanib Strength: 1.34 mg Dosage Form: Oral Capsules Therapeutic Category: Anti-Cancer / VEGFR Tyrosine Kinase Inhibitor Packaging: Blister pack / export carton packaging Shelf Life: 24–36 months Storage: Store below 25°C in a dry place Benefits of TIVOXEN Capsules • Advanced targeted therapy for kidney cancer • Helps slow tumor growth and disease progression • Effective VEGFR inhibitor used in oncology treatment • Oral capsule formulation for convenient treatment • Used in modern renal cancer therapy worldwide • Suitable for long-term targeted cancer treatment Why Choose Ernest Oncology? Ernest Oncology is a leading pharmaceutical exporter from India, supplying high-quality medicines to pharmaceutical distributors, hospitals, and healthcare institutions worldwide. Key advantages include: • GMP certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable international pharmaceutical distribution network • OEM and private labeling options available • Fast global delivery via DHL, Aramex & Air Cargo • Trusted supplier of oncology medicines and specialty drugs Export Documentation Provided For international pharmaceutical shipments, Ernest Impex provides complete documentation including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

TUCANAT 150 MG Tablet (Tucatinib) Exporter & Global Oncology Supplier – Ernest Oncology TUCANAT 150 MG Tablet is an advanced targeted anti-cancer medication containing Tucatinib, used primarily for the treatment of HER2-positive breast cancer, particularly in patients with advanced or metastatic disease. Ernest Oncology is a trusted pharmaceutical exporter from India, supplying TUCANAT 150 MG tablets globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and medical procurement agencies. Pharmaceutical importers and healthcare providers across Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) depend on Ernest Impex for bulk supply of Tucatinib tablets with reliable global delivery and competitive export pricing. What is TUCANAT 150 MG Tablet? TUCANAT 150 MG Tablet contains Tucatinib, a targeted HER2 tyrosine kinase inhibitor used in combination therapy for the treatment of HER2-positive metastatic breast cancer. Tucatinib is designed to specifically block HER2 signaling pathways that promote cancer cell growth and tumor progression. This targeted therapy helps improve treatment outcomes when used alongside other anti-cancer medicines such as trastuzumab and capecitabine. Because of its clinical effectiveness, Tucatinib is considered a significant advancement in HER2-positive breast cancer therapy worldwide. Mechanism of Action The active ingredient Tucatinib works by selectively inhibiting the HER2 tyrosine kinase receptor, which plays a major role in the growth of certain breast cancer cells. By blocking HER2 signaling pathways, Tucatinib: • Prevents cancer cell growth and proliferation • Inhibits tumor progression • Enhances the effectiveness of combination therapies • Improves outcomes in HER2-positive metastatic breast cancer This targeted mechanism allows TUCANAT tablets to specifically attack cancer cells while minimizing damage to normal cells. Medical Uses of TUCANAT 150 MG TUCANAT tablets are primarily prescribed for: • HER2-positive metastatic breast cancer • Advanced breast cancer resistant to other treatments • Combination therapy with trastuzumab and capecitabine • Patients with brain metastases associated with HER2-positive cancer Tucatinib has become a critical targeted therapy medicine in modern oncology treatment programs. Product Information Product Name: TUCANAT 150 MG Tablet Generic Name: Tucatinib Strength: 150 mg Dosage Form: Oral Tablet Therapeutic Category: Anti-Cancer / HER2 Tyrosine Kinase Inhibitor Packaging: Blister Pack / Export Carton Packaging Shelf Life: 24–36 Months Storage: Store below 25°C in a cool and dry place Benefits of TUCANAT Tablets • Advanced targeted therapy for HER2-positive breast cancer • Helps slow tumor growth and progression • Effective in metastatic breast cancer treatment • Often used in combination with other cancer therapies • Oral tablet for convenient long-term treatment • Widely used in oncology hospitals and cancer treatment centers Why Choose Ernest Impex? Ernest Impex is a leading pharmaceutical exporter from India, supplying high-quality medicines to pharmaceutical distributors, hospitals, and healthcare institutions worldwide. Key advantages include: • GMP certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable global pharmaceutical distribution network • OEM and private labeling options available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted supplier for oncology medicines and hospital drugs Export Documentation Provided Ernest Oncology provides complete export documentation for international pharmaceutical shipments including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

Endace 160mg (Megestrol) Tablet – Global Supplier & Exporter |Ernest Oncology Endace 160mg (Megestrol) Tablet – Appetite Stimulant & Oncology Support Medicine Endace 160mg Tablet (Megestrol Acetate) is a widely used medication in oncology and clinical nutrition therapy. It is primarily prescribed to treat loss of appetite, severe weight loss, and cachexia in cancer or AIDS patients. The medicine works as a synthetic progestin hormone that helps stimulate appetite, increase body weight, and improve nutritional intake in patients suffering from chronic illness. Ernest Oncology a leading pharmaceutical exporter from India, supplies Endace 160mg (Megestrol) Tablets to hospitals, distributors, pharmacies, and medical procurement companies across the globe including Washington DC, New York, London, Riyadh, Bangkok, Canberra, Singapore, and Kingston Jamaica. What is Endace 160mg (Megestrol) Tablet? Endace contains Megestrol Acetate 160mg, a synthetic derivative of the hormone progesterone. It is commonly prescribed in oncology supportive care and clinical nutrition to manage anorexia, cachexia, and unexplained weight loss. Megestrol helps increase appetite and caloric intake, leading to weight gain and improved overall strength in patients undergoing long-term illness treatments. This medicine is frequently used in: • Cancer-related weight loss • AIDS-related anorexia • Hormone-responsive cancers • Severe malnutrition caused by chronic disease Mechanism of Action of Megestrol Acetate Megestrol acetate acts as a progestational hormone and affects the hypothalamic appetite regulation center in the brain. Key actions include: • Stimulates appetite and increases food intake • Promotes fat deposition and weight gain • Reduces inflammatory cytokines involved in cachexia • Supports nutritional recovery in chronic illness patients Because of these effects, it is widely used in oncology supportive therapy and palliative care. Medical Uses of Endace 160mg Tablet Endace 160 mg Tablets are prescribed by doctors for several clinical conditions, including: Cancer-Related Cachexia Patients undergoing cancer therapy often suffer from severe weight loss. Megestrol helps improve appetite and nutritional status. AIDS-Related Weight Loss Used to manage HIV/AIDS-associated anorexia and wasting syndrome. Hormone-Sensitive Cancers Sometimes used in treatment protocols for breast cancer and endometrial cancer. Chronic Disease Malnutrition Helps improve body weight and strength in patients suffering from chronic illnesses. Benefits of Endace 160mg (Megestrol) Tablet • Powerful appetite stimulant • Helps patients gain weight and strength • Improves nutritional status in cancer patients • Supports recovery during long-term illness • Widely used in oncology supportive therapy • Recommended by healthcare professionals worldwide Product Information Product Name: Endace 160mg Tablet Generic Name: Megestrol Acetate Strength: 160 mg Dosage Form: Tablet Therapeutic Class: Hormonal / Appetite Stimulant Packaging: As per manufacturer packaging Prescription: Required Global Demand for Megestrol Tablets Megestrol Acetate medicines such as Endace 160mg Tablet are widely demanded in the global pharmaceutical market due to increasing cases of cancer, HIV/AIDS, and chronic diseases causing cachexia. Hospitals and medical distributors frequently import this medicine from GMP certified pharmaceutical exporters in India. Exporter & Supplier of Endace 160mg Tablet Ernest Oncology is a trusted global pharmaceutical exporter and distributor of oncology and specialty medicines from India. We supply high-quality medicines to international buyers including hospitals, wholesalers, government tenders, NGOs, and medical importers. Our export network covers major international healthcare markets including: USA, UK, Saudi Arabia, Thailand, Australia, Singapore, and Jamaica. Why Buy From Ernest Impex? • Trusted Pharmaceutical Exporter from India • Global supply network in 100+ countries •GMP compliant medicines • Competitive bulk pricing • Fast international shipping • Export documentation support • Reliable packaging and cold-chain handling when required Export Documentation Provided Ernest Oncology provides complete pharmaceutical export documentation including: • Certificate of Analysis (COA) • Manufacturing License • MSDS (Material Safety Data Sheet) • Product Batch Release Certificate • Commercial Invoice & Packing List • Airway Bill (DHL / Aramex / FedEx) • Country of Origin Certificate These documents ensure smooth international customs clearance. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier www.ernestimpex.com www.ernestvision.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 WhatsApp Direct Link https://wa.me/919359902383

DUTAXEL 100MG Injection (Docetaxel) Exporter & Global Oncology Supplier – Ernest Oncology DUTAXEL 100MG Injection is a widely used anti-cancer chemotherapy medicine containing Docetaxel, used for the treatment of multiple types of cancers including breast cancer, lung cancer, prostate cancer, gastric cancer, and head & neck cancer. Ernest Oncology is a trusted pharmaceutical exporter from India, supplying DUTAXEL 100MG Injection globally to oncology hospitals, cancer treatment centers, pharmaceutical distributors, and healthcare procurement companies. Pharmaceutical importers and healthcare providers across Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely on Ernest Impex for bulk supply of Docetaxel injections with reliable global delivery and competitive export pricing. What is DUTAXEL 100MG Injection? DUTAXEL 100MG Injection contains Docetaxel, a chemotherapy medication belonging to the taxane class of anti-cancer drugs. It is used to treat various cancers by inhibiting cancer cell growth and preventing cell division. Docetaxel is administered through intravenous infusion under medical supervision in hospitals and oncology clinics. Due to its proven clinical effectiveness, it is widely used in modern oncology treatment protocols worldwide. Mechanism of Action The active ingredient Docetaxel works by stabilizing microtubules within cancer cells and preventing their breakdown during the cell cycle. This interference blocks the normal process of mitosis (cell division). Docetaxel helps fight cancer by: • Preventing microtubule disassembly • Blocking cancer cell division • Inducing programmed cancer cell death (apoptosis) • Slowing tumor growth and spread This targeted mechanism makes DUTAXEL Injection an effective chemotherapy treatment for several malignancies. Medical Uses of DUTAXEL 100MG Injection DUTAXEL injection is commonly prescribed for: • Breast Cancer • Non-Small Cell Lung Cancer (NSCLC) • Prostate Cancer • Gastric Cancer • Head and Neck Cancer Docetaxel may be used alone or in combination with other chemotherapy medicines to improve treatment outcomes in cancer therapy. Product Information Product Name: DUTAXEL 100MG Injection Generic Name: Docetaxel Strength: 100 mg Dosage Form: Injection (Intravenous Infusion) Therapeutic Category: Anti-Cancer / Chemotherapy / Taxane Packaging: Single vial with export carton packaging Shelf Life: 24–36 months Storage: Store below 25°C in a cool and dry place Benefits of DUTAXEL Injection • Effective chemotherapy drug for multiple cancers • Widely used in oncology treatment programs • Helps slow tumor growth and cancer progression • Reliable hospital-grade injectable formulation • Globally recognized anti-cancer medicine • Suitable for combination chemotherapy regimens Why Choose Ernest Oncology? Ernest Oncology is a global pharmaceutical exporter based in India, delivering high-quality medicines to pharmaceutical distributors, hospitals, and healthcare organizations worldwide. Key advantages include: • GMP-certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable international shipping • OEM and private labeling options available • Fast delivery via DHL, Aramex & Air Cargo • Trusted supplier of oncology medicines and hospital drugs Export Documentation Provided Ernest Oncology provides complete export documentation for international pharmaceutical shipments including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact r Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

DUTAXEL 260MG Injection (Docetaxel) Exporter & Global Bulk Supplier – Ernest Oncology DUTAXEL 260MG Injection is a widely used anti-cancer chemotherapy medication containing Docetaxel, designed for the treatment of several types of cancers including breast cancer, lung cancer, prostate cancer, gastric cancer, and head & neck cancers. Ernest Oncology is a trusted pharmaceutical exporter from India, supplying DUTAXEL 260MG Injection globally to oncology hospitals, pharmaceutical distributors, cancer treatment centers, and medical procurement agencies. Healthcare providers and pharmaceutical importers in Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) rely on Ernest Impex for bulk supply of Docetaxel injections with reliable global logistics and competitive export pricing. What is DUTAXEL 260MG Injection? DUTAXEL 260MG Injection contains Docetaxel, a chemotherapy drug belonging to the taxane class of anti-cancer medicines. Docetaxel is used in oncology treatments to slow or stop the growth of cancer cells by interfering with cell division. This medicine is administered intravenously under the supervision of medical professionals in hospitals and oncology clinics. Because of its effectiveness in treating multiple cancers, Docetaxel is considered an important chemotherapy medicine in modern cancer treatment protocols. Mechanism of Action The active ingredient Docetaxel works by stabilizing microtubules in cancer cells and preventing them from breaking down. This process disrupts the normal cell division cycle, leading to the death of rapidly dividing cancer cells. Docetaxel works by: • Preventing microtubule disassembly • Blocking cancer cell division (mitosis) • Inducing apoptosis (programmed cancer cell death) • Slowing tumor growth and spread This targeted action makes DUTAXEL Injection an effective chemotherapy treatment for several malignancies. Medical Uses of DUTAXEL 260MG Injection DUTAXEL injection is used in the treatment of: • Breast Cancer • Non-Small Cell Lung Cancer (NSCLC) • Prostate Cancer • Gastric Cancer • Head and Neck Cancer Docetaxel is often used alone or in combination with other chemotherapy drugs to improve treatment outcomes in oncology patients. Product Information Product Name: DUTAXEL 260MG Injection Generic Name: Docetaxel Strength: 260 mg Dosage Form: Injection (IV Infusion) Therapeutic Category: Anti-Cancer / Chemotherapy / Taxane Packaging: Vial with Export Carton Packaging Shelf Life: 24–36 Months Storage: Store in a cool and dry place below 25°C Benefits of DUTAXEL Injection • Effective chemotherapy drug for multiple cancers • Widely used in oncology treatment protocols • Helps slow tumor growth and cancer progression • Reliable injectable formulation used in hospitals • Globally recognized anti-cancer medicine • Suitable for combination chemotherapy regimens Why Choose Ernest Oncology? Ernest Oncology is a global pharmaceutical exporter based in India, delivering high-quality medicines to pharmaceutical distributors, hospitals, and healthcare organizations worldwide. Key advantages: • GMP certified pharmaceutical sourcing • Competitive export pricing for bulk buyers • Reliable global pharmaceutical distribution network • OEM and private labeling available • Fast international delivery via DHL, Aramex & Air Cargo • Trusted supplier for oncology medicines and hospital drugs Export Documentation Provided For international pharmaceutical shipments, Ernest Oncology provides complete export documentation including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents help ensure smooth customs clearance and regulatory compliance for pharmaceutical imports worldwide. 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF PHARMACEUTICAL PVT. LTD] 🌐 Websites www.oncologymediciensuppiler.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383

DASATIB 70MG Tablet (Dasatinib) Exporter & Global Bulk Supplier – Ernest Oncology DASATIB 70MG Tablet (Dasatinib) is an advanced targeted anti-cancer medication used in the treatment of certain types of leukemia. Ernest Oncology is a trusted pharmaceutical exporter from India, supplying DASATIB 70MG tablets globally to pharmaceutical distributors, hospitals, oncology clinics, and healthcare procurement agencies. Healthcare providers and pharmaceutical importers in Washington (USA), London (UK), Riyadh (Saudi Arabia), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica) depend on Ernest Oncologyfor bulk supply of Dasatinib tablets with reliable international logistics and competitive export pricing. What is DASATIB 70MG Tablet? DASATIB 70MG Tablet contains Dasatinib, a tyrosine kinase inhibitor used primarily in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Dasatinib works by targeting specific proteins responsible for the uncontrolled growth of cancer cells. By blocking these signals, the medicine helps slow or stop the growth of leukemia cells, improving treatment outcomes. Because of its targeted mechanism, Dasatinib has become a critical medicine in modern oncology therapy worldwide. Mechanism of Action The active ingredient Dasatinib belongs to a class of medications known as tyrosine kinase inhibitors (TKIs). Dasatinib works by inhibiting several key kinases including: • BCR-ABL kinase • SRC family kinases • c-KIT receptor kinase • Platelet-derived growth factor receptor (PDGFR) By blocking these signaling pathways, Dasatinib: • Prevents cancer cell proliferation • Reduces leukemia progression • Induces apoptosis (cancer cell death) • Improves hematologic response in leukemia patients This targeted therapy approach makes DASATIB 70MG tablets a highly effective treatment for certain blood cancers. Medical Uses of DASATIB 70MG Tablet DASATIB tablets are prescribed for the treatment of: • Chronic Myeloid Leukemia (CML) • Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) • Patients resistant or intolerant to previous leukemia therapies • Targeted therapy for advanced leukemia conditions Dasatinib is widely used in oncology treatment programs and specialized cancer care centers globally. Product Information Product Name: DASATIB 70MG Tablet Generic Name: Dasatinib Strength: 70 mg Dosage Form: Oral Tablet Therapeutic Category: Anti-Cancer / Tyrosine Kinase Inhibitor Packaging: Blister Pack / Export Carton Shelf Life: 24–36 Months Storage: Store below 25°C in a dry place Benefits of DASATIB Tablets • Targeted anti-cancer therapy • Effective treatment for leukemia patients • Helps slow cancer progression • Oral tablet formulation for convenient therapy • Widely used in oncology treatment protocols • Advanced targeted therapy for blood cancers Why Choose Ernest Oncology? Ernest Oncology is a reliable global pharmaceutical exporter from India, supplying high-quality medicines to more than 50 international markets. Key advantages include • GMP certified pharmaceutical supply • Competitive bulk pricing for distributors • Reliable international shipping • OEM and private labeling options available • Fast global delivery via DHL, Aramex & Air Cargo • Trusted supplier for hospitals and oncology distributors We support pharmaceutical wholesalers, hospital procurement teams, NGOs, and healthcare importers worldwide. Export Documentation Provided Ernest Impex provides complete export documentation for international pharmaceutical shipments including: • Certificate of Analysis (COA) • Material Safety Data Sheet (MSDS) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill / Shipping Documents • GMP Certificate • Certificate of Origin (if required) These documents ensure smooth international pharmaceutical import and customs clearance. 📞 Contact Ernest Oncology – Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp +91 93599 02383 🔗 Direct WhatsApp https://wa.me/919359902383